About StageBio
StageBio is a Healthcare company based in Mount Jackson (United States) founded in 2001. Preclinical pathology services are provided for research and development needs. StageBio has completed 1 acquisition, including TPL Path Labs. StageBio offers products and services including Lab Services, Pathology Services, Biorepository Services, and Consulting Services. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Pathology & Imaging. Its legal entity is HSRL Holdings LLC. Its competitors include Asterand Bioscience, Numira and Numira Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
StageBio was founded in 2001 and is based in Mount Jackson, United States. Preclinical pathology services are offered by the company within the biotechnology and pharmaceutical sectors. Operations focus on histopathological analysis, toxicologic pathology, and related support for drug discovery and safety assessment. Expertise is applied to nonclinical studies, with services extending to digital pathology and consulting for global clients in the life sciences industry.
- Headquarters Mount Jackson, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website stagebio.com
- Social LinkedIn X
- Legal Name Hsrl Holdings Llc
- Investors
- Investments & Acquisitions
Products & Services of StageBio
StageBio offers a comprehensive portfolio of products and services, including Lab Services, Pathology Services, Biorepository Services, and Consulting Services.
Provides testing for preclinical and clinical research programs.
Offers analysis of tissue samples for biopharmaceutical applications.
Manages specimen archiving and secure storage solutions.
Delivers expert advice on pathology and research needs.
Funding Insights of StageBio
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of StageBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2018 | Seed | – | Ampersand Capital | – |
1 investors in total: 1 institutional.
Investors in StageBio
StageBio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | ampersandcapital.com | Boston, United States |
Investor details for StageBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of StageBio
16 people are tracked at StageBio (6 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Carrie Harris | VP, Study Solutions | Leadership |
Sam Jeffrey | VP, Biorepository & Supply Chain | Leadership |
Vicky Cook | Quality Assurance Director | Leadership |
Ed Galati | Director Of Archive Client Relations | Leadership |
Dane Brady | Director Project Management | Leadership |
Shehnaz Jaffar Kataria | Chief Financial Officer | Leadership |
Ayse Bal | MD, Germany | Team |
Serge Rousselle | Distinguished Pathologist | Team |
Vandita Patel | Quality Assurance Auditor II | Team |
Lindsey Anderson | Staff Accountant | Team |
Beth Taylor | Quality Assurance Auditor | Team |
Janet Shock | System Administrator II | Team |
Renee Yoder | Controller | Team |
Katie Satterfield | Scheduling Coordinator | Team |
Layne Fadely | Client Services Manager | Team |
Kathleen Attamante | Senior Research Associate | Team |
Complete people profiles for StageBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by StageBio
StageBio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TPL Path Labs.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Diagnostic pathology services are offered by a standalone laboratory. | tpl-path-labs.com | 2008 | Oct 2020 | •••• |
Complete acquisition details for StageBio
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of StageBio
3 dated milestones of StageBio across 19 years, from founding to its latest funding, stage changes and deals.
- Founded StageBio is founded.
- Funding First funding round.
- Acquisition Acquires TPL Path Labs.
Competitors of StageBio
StageBio has 3 listed competitors in our database, 3 of them funded. They include Asterand Bioscience, Numira and Numira Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asterandbio.com | 2000 | Detroit, United States | $7.11M | Human tissue solutions for drug discovery research are supplied globally. | ||
| numira.com | 2005 | Salt Lake, United States | $5.78M | Numira is a specialty preclinical CRO specializing in microCT imaging, image analysis, histology, and 3D cancer cell profiling. | ||
| numirabio.com | 2005 | Salt Lake, United States | $5.78M | Online platform for fast deposits and retail in electronics and fashion categories. |
Detailed competitors of StageBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of StageBio
The website of StageBio (stagebio.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▼ 6.3% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as StageBio (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Stagebio
Complete news archive for StageBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about StageBio
StageBio was founded in 2001 and raised its 1st funding round 17 years after it was founded.
StageBio is headquartered in Mount Jackson, United States. It is registered at Mount Jackson, Virginia, United States.
StageBio was founded in 2001 and is based in Mount Jackson, United States. Preclinical pathology services are offered by the company within the biotechnology and pharmaceutical sectors. Operations focus on histopathological analysis, toxicologic pathology, and related support for drug discovery and safety assessment. Expertise is applied to nonclinical studies, with services extending to digital pathology and consulting for global clients in the life sciences industry.
StageBio's top competitors include Asterand Bioscience, Numira and Numira Biosciences.
StageBio offers Lab Services, Pathology Services, Biorepository Services, and Consulting Services.
StageBio has made 1 acquisition, including TPL Path Labs.
StageBio has 1 investor. Key investors include Ampersand Capital Partners.
StageBio operates through Hsrl Holdings Llc.